The UB study focuses on non-critical patients, who make up the majority of COVID-19 cases, and potentially pose the highest risk to spread the disease.
In research led by UB professor Teresa Quattrin, golimumab preserved beta-cell function in children and young adults with newly diagnosed Type 1 diabetes.
The research aims to identify the role of rapid and quantitative testing for individuals with COVID-19, their family members and other high-risk groups.
Family caregivers' fatigue and sleep problems are common symptoms, but are underrecognized and unmanaged, according to results of a new study led by nursing professor Yu-Ping Chang.